A new fat-dissociation method to detect lymph nodes in colorectal cancer: a prospective randomized study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 06 02 2020
accepted: 26 10 2020
entrez: 20 11 2020
pubmed: 21 11 2020
medline: 14 1 2021
Statut: epublish

Résumé

Histological examination of the lymph nodes (LNs) is crucial to determine the colorectal cancer (CRC) stage. We previously reported a new fat-dissociation method (FM) to detect LNs from surgically resected mesentery. This study aimed to examine the effectiveness of FM compared with that of conventional palpation method (PM) in CRC. This single-center, open-label, randomized controlled study was performed at Osaka International Cancer Institute in Japan in 2014. Randomization was performed using a computer-generated permuted-block sequence. Patients were stratified by surgical procedures and the LN dissection area. The primary endpoint was the time required for LN identification. The secondary endpoint was the number of LNs and 5-year cancer-specific survival. The 130 enrolled patients were randomly assigned in a 1:1 ratio to the FM and the PM groups. LN identification times were 45 (range 15-80) and 15 (range 7-30) minutes in the PM and the FM groups, respectively (P < 0.001). In the PM group, body mass index and identification time were correlated (P = 0.047). The number of LN which could be examined pathologically was 16 (range 2-48) and 18 (range 4-95) in the PM and FM groups, respectively (P = 0.546). In right-sided CRC, the number of LNs was higher in the FM group than in the PM group (P = 0.031). Relapse-free survival rates and cancer-specific survival rates did not differ between the groups. In conclusion, FM reduced the time required for LN detection without reducing the number of detected LNs, making it is a useful method to detect LNs in surgical specimens.

Identifiants

pubmed: 33214579
doi: 10.1038/s41598-020-77195-8
pii: 10.1038/s41598-020-77195-8
pmc: PMC7678840
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20205

Références

Int J Clin Oncol. 2015 Apr;20(2):207-39
pubmed: 25782566
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Cancer Epidemiol. 2016 Dec;45:65-70
pubmed: 27716537
Ann Oncol. 2012 Oct;23(10):2479-2516
pubmed: 23012255
Oncol Rep. 2014 Sep;32(3):922-6
pubmed: 25017814
Cancer. 2011 Oct 1;117(19):4365-74
pubmed: 21437889
Int J Clin Oncol. 2012 Feb;17(1):1-29
pubmed: 22002491
Lung Cancer. 2016 Jul;97:1-7
pubmed: 27237020
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gynecol Oncol. 2016 Oct;143(1):54-59
pubmed: 27498395
Surg Today. 2020 Jul;50(7):726-733
pubmed: 31912338
Dis Colon Rectum. 1994 Mar;37(3):219-23
pubmed: 8137667
World J Gastrointest Surg. 2020 Jun 27;12(6):277-286
pubmed: 32774766
Ann Surg Oncol. 2012 Nov;19(12):3865-70
pubmed: 22618721
Ann Oncol. 2013 Oct;24 Suppl 6:vi81-8
pubmed: 24078665
Clin Cancer Res. 2016 Jul 1;22(13):3201-8
pubmed: 26831719
Ann Surg Oncol. 2011 Jul;18(7):1891-8
pubmed: 21290195
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Dis Colon Rectum. 2013 Sep;56(9):1028-35
pubmed: 23929011
Arch Pathol Lab Med. 2001 May;125(5):642-5
pubmed: 11300935
Int J Clin Oncol. 2017 Feb;22(1):3-10
pubmed: 27549784
Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72
pubmed: 24078664
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
Arch Pathol Lab Med. 2009 Jan;133(1):83-6
pubmed: 19123742
J Am Coll Surg. 1994 Mar;178(3):223-8
pubmed: 8149012

Auteurs

Shiki Fujino (S)

Innovative Oncology Research and Translational Medicine, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Norikatsu Miyoshi (N)

Innovative Oncology Research and Translational Medicine, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan. nmiyoshi@gesurg.med.osaka-u.ac.jp.
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. nmiyoshi@gesurg.med.osaka-u.ac.jp.

Masayuki Ohue (M)

Department of Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Aya Ito (A)

Innovative Oncology Research and Translational Medicine, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Masayoshi Yasui (M)

Department of Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Takayuki Ogino (T)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Hidekazu Takahashi (H)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Mamoru Uemura (M)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Chu Matsuda (C)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Hirofumi Yamamoto (H)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Tsunekazu Mizushima (T)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Yuichiro Doki (Y)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Hidetoshi Eguchi (H)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Nariaki Matsuura (N)

Department of Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH